What is another name for Guillain-Barré Syndrome (GBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Guillain-Barré syndrome is also known as acute inflammatory demyelinating polyradiculoneuropathy (AIDP), which is the most common alternative medical name for this condition. Other names include acute polyradiculoneuritis, Landry-Guillain-Barré syndrome, and post-infectious polyneuritis. These alternative names reflect the condition's key characteristics: it's an acute disorder affecting multiple nerve roots and peripheral nerves, causing inflammation and demyelination, as described in 1. The condition was named after two French neurologists, Georges Guillain and Jean Alexandre Barré, who first described it in 1916, along with André Strohl. The syndrome represents an autoimmune disorder where the body's immune system mistakenly attacks the peripheral nerves, often following a respiratory or gastrointestinal infection, as discussed in 2. This immune response damages the myelin sheath covering nerve fibers, disrupting nerve signal transmission and causing the characteristic symptoms of muscle weakness, tingling sensations, and in severe cases, paralysis. Some of the key characteristics and clinical features of Guillain-Barré syndrome are outlined in 3, including the frequency of the condition and its division into two major subtypes: acute inflammatory demyelinating polyneuropathy (AIDP) and the axonal subtypes. Additionally, 4 reviews both typical GBS (AIDP, AMAN, and AMSAN), and variant syndromes with a focus on clinical and diagnostic features, pathologic findings, pathogenesis, and treatment. It's worth noting that while older studies like 5 provide valuable information on the condition, more recent studies like 2 offer a more up-to-date understanding of Guillain-Barré syndrome. Key points to consider when diagnosing and treating Guillain-Barré syndrome include:

  • The condition's acute onset and rapid progression
  • The importance of early diagnosis and treatment
  • The use of immunotherapy, including plasma exchange (PE) or intravenous immunoglobulin (IVIg), to shorten the time to recovery
  • The need for meticulous monitoring and supportive care to manage symptoms and prevent complications.

References

Research

Acute polyradiculoneuritis: Guillain-Barré syndrome.

Handbook of clinical neurology, 2013

Research

Guillain-Barré syndrome.

Autoimmunity reviews, 2017

Research

The Guillain-Barré syndrome.

Handbook of clinical neurology, 2013

Research

Guillain-Barré syndrome.

Seminars in neurology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.